ID NOW™ COVID-19 by Abbott

Manufacturer Abbott  |  Available in North America
4.8
/
5.0
  |  4 reviews
Molecular. In minutes. On the front line.


ID NOW™ COVID-19 by Abbott product image
ID NOW™ COVID-19

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.




Average Rating: 4.8
4 Scientists have reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money


  • Status:

    Advanced Reviewer
  • Member since: 2019

  • Organization: Adena Health System



  • Ease of use
    5 out of 5
    After sales service
    4 out of 5
    Value for money
    4 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Useful analyzer
Rating: 4.3

  • Application Area: Covid-19

"Easy to use, and test is completed at the point of care. Results in 15 minutes. Other test can be run on the instrument."

Review date: 19 Nov 2021 | ID NOW™ COVID-19
  • Status:

    Advanced Reviewer

  • Member since: 2021

  • Organization: Upland Hills Health



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this ReviewShare this Review on TwitterShare this Review
Very essential during this pandemic and supply chain issues.
Rating: 5.0

  • Application Area:Testing samples for COVID-19

"This instrument has been a life saver for us as an additional platform for COVID testing. With supply shortages everywhere, we have come to rely on the consistent supply of COVID testing kits we have received. We have three of these units in our lab and they are well used with no issues. We have had very few invalid results and if we have an invalid times two on a sample, we run it on a different platform. QC is included with the kit so there is no extra expense."

Review date: 15 Nov 2021 | ID NOW™ COVID-19
  • Status:

    Advanced Reviewer

  • Member since: 2021

  • Organization: Upland Hills Health



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this ReviewShare this Review on TwitterShare this Review
Lifesaver for our small hospital lab.
Rating: 5.0

  • Application Area:Testing samples for COVID-19

"These little analyzers have been a saving grace for us during this pandemic. They are fast, easy to use, accurate and supplies are fairly easy to get."

Review date: 24 Sep 2021 | ID NOW™ COVID-19
  • Status:

    Reviewer

  • Member since: 2020

  • Organization: Anaheim Clinical Trials



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this ReviewShare this Review on TwitterShare this Review
Always saving the day!
Rating: 5.0

  • Application Area:Diagnostic

"We are able to perform point of care COVID19 test in less than 20 minutes helping with our logistics."

Review date: 09 Feb 2021 | ID NOW™ COVID-19

The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.

Timely results enable healthcare professionals to make appropriate and more efficient treatment and infection control decisions. EUA supports flexible near-patient testing environments.

Benefits:

  • Positive results may be detected in as little as 5 minutes 
  • Negative results in 13 minutes
  • Molecular technology targeting COVID-19 RdRp gene
  • Designed for near-patient testing in a variety of healthcare environments
  • Room temperature storage
  • Direct sample types include: Nasal, Throat, and Nasopharyngeal swabs
  • Facilitates effective patient management